Anuj Sharma co-founded Decrypt Biomedicine, where he served as CTO from 2022 to 2024 and now sits on the board. Decrypt is a biotech developing first-in-class small-molecule treatments for autoimmune disease by drugging 'cryptic' binding sites on hard-to-target proteins. His co-founder is Greg Bowman. Sharma is now a research engineer at Google DeepMind and holds a B.A. and an M.S. from Columbia University.